HomeCompareNBPVF vs MRK

NBPVF vs MRK: Dividend Comparison 2026

NBPVF yields 5.32% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NBPVF wins by $8.13M in total portfolio value
10 years
NBPVF
NBPVF
● Live price
5.32%
Share price
$17.55
Annual div
$0.93
5Y div CAGR
64%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$8.19M
Annual income
$6,483,800.67
Full NBPVF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — NBPVF vs MRK

📍 NBPVF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNBPVFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NBPVF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NBPVF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NBPVF
Annual income on $10K today (after 15% tax)
$452.60/yr
After 10yr DRIP, annual income (after tax)
$5,511,230.57/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, NBPVF beats the other by $5,502,902.16/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NBPVF + MRK for your $10,000?

NBPVF: 50%MRK: 50%
100% MRK50/50100% NBPVF
Portfolio after 10yr
$4.12M
Annual income
$3,246,799.40/yr
Blended yield
78.78%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

NBPVF
No analyst data
Altman Z
6.1
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NBPVF buys
0
MRK buys
0
No recent congressional trades found for NBPVF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNBPVFMRK
Forward yield5.32%2.76%
Annual dividend / share$0.93$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR64%32.7%
Portfolio after 10y$8.19M$56.8K
Annual income after 10y$6,483,800.67$9,798.13
Total dividends collected$8.01M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: NBPVF vs MRK ($10,000, DRIP)

YearNBPVF PortfolioNBPVF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,573$873.25$11,206$366.19+$367.00NBPVF
2$13,932$1,549.00$12,650$502.35+$1.3KNBPVF
3$17,766$2,858.13$14,407$694.19+$3.4KNBPVF
4$24,595$5,586.00$16,585$967.82+$8.0KNBPVF
5$38,170$11,853.06$19,342$1,363.89+$18.8KNBPVF
6$69,036$28,194.25$22,913$1,947.19+$46.1KNBPVF
7$152,027$78,158.19$27,662$2,823.89+$124.4KNBPVF
8$426,471$263,801.93$34,159$4,173.35+$392.3KNBPVF
9$1,590,568$1,134,244.37$43,337$6,308.80+$1.55MNBPVF
10$8,185,709$6,483,800.67$56,776$9,798.13+$8.13MNBPVF

NBPVF vs MRK: Complete Analysis 2026

NBPVFStock

NB Private Equity Partners Limited specializes in private equity fund of funds and co-investments. In fund of fund investments, it invests in private equity fund managed by other sponsors and funds of funds managed by the investment manager. In co-investments, it makes direct investments alongside other sponsors. Within direct investments the fund specializes in buyout. The fund seeks to invest in industrials, technology, transportation, business services, communications and media, consumer discretionary, energy, financial services and healthcare. It mainly prefers to invest in North America, followed by Europe and Asia. It also prefers to take majority stake in its portfolio companies.

Full NBPVF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this NBPVF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NBPVF vs SCHDNBPVF vs JEPINBPVF vs ONBPVF vs KONBPVF vs MAINNBPVF vs JNJNBPVF vs ABBVNBPVF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.